

Legal Notice
Applicable law
Any legal claims or lawsuits in conjunction with this website or
its use are exclusively subject to the laws of the Federal Republic
of Germany, except for the provisions of international private law
and the HIndiaue Convention relating to a Uniform Law on the
International Sale of Goods of July 1, 1964 and in the UN Sales
Convention of April 11, 1980.
- ACTIVE PHARMACEUTICAL INGREDIENTS:
- Gabapentin
- Pregabalin
- Tioconazole
- Lamotrigine
- Lacosamide
- Ondansetron HCL
- Tenoxicam
- NEW PRODUCTS DEVELOPED IN R & D
- Quetiapine (UNDER PROCESS)
- INTERMEDIATES
- 2,3-Dichloro Benzoyl Chloride [2905-60-4]
End Product - Lamotrigine - 3-(Carbamoylmethyl)-5-Methyl Hexanoic Acid [181289-15-6]
End Product - Pregabalin - 3-Aminomethyl-5-Methyl Hexanoic Acid [128013-69-4]
End Product - Pregabalin - N6-Trifluoroacetyl-L-Lysine [10009-20-8]
End Product - Lisinopril - 4-(2,3-EpoxyPropoxy)-Carbazole [51997-51-4]
End Product - Carvedilol
- Press Releases
- December 30,2011
- Every operational division atSienna Biotec Pvt. Ltd. aims to achieve the right result over time by following the validated method.
- January 1, 2019
- Every step of production process is carefully monitored & controlled.
- January 3,2019
- Sienna Biotec Pvt. Ltd. with a simple objective -facilitating the manufacture of complex API'sproducts.
- January 5, 2019
- Every step of production process is carefully monitored & controlled.
- January 8,2019
- Sienna Biotec Pvt. Ltd. with a simple objective -facilitating the manufacture of complex API'sproducts.

.jpg)
